← Open Payments lookup

MATTHEW DICKISON: Open Payments

NPI 1467794776 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$983 in 51 payments from 10 companies in 2025. Trend: 2023 $343 · 2024 $378 · 2025 $983

Food & beverage: $879Education: $104
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.19$302
Janssen Pharmaceuticals, Inc13$177
Braeburn Inc.1$130
Alkermes, Inc.5$95
Indivior Inc.4$88
Neurocrine BioSciences, Inc.3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Otsuka America Pharmaceutical, Inc.2$34
E.R. Squibb & Sons, L.L.C.1$26
Luye Pharma (USA) Ltd.1$19

Products named: UZEDY, INVEGA SUSTENNA, BRIXADI, ARISTADA, SUBLOCADE, INGREZZA, SPRAVATO, CAPLYTA.

Industry payments across CT — which companies pay providers there.